GDF‐15 in solid vs non‐solid treatment‐naïve malignancies

AIM: GDF‐15 is an established cardiovascular risk marker but is equally implicated in tumour biology. Elevated levels of GDF‐15 have indeed been observed in distinct tumour entities. This study aimed to explore the relation of GDF‐15 to other cardiac biomarkers and the general association of GDF‐15...

Descripción completa

Detalles Bibliográficos
Autores principales: Arfsten, Henrike, Cho, Anna, Freitag, Claudia, Raderer, Markus, Goliasch, Georg, Bartko, Philipp E., Wurm, Raphael, Strunk, Guido, Gisslinger, Heinz, Marosi, Christine, Kornek, Gabriela, Zielinski, Christoph, Hülsmann, Martin, Pavo, Noemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899906/
https://www.ncbi.nlm.nih.gov/pubmed/31463975
http://dx.doi.org/10.1111/eci.13168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899906/
https://www.ncbi.nlm.nih.gov/pubmed/31463975
http://dx.doi.org/10.1111/eci.13168

Ejemplares similares